Tafamidis: A Game Changer in Transthyretin Cardiomyopathy? A Systematic Review of Efficacy and Safety

被引:0
|
作者
Hussain, Bilal
Hamza, Mohammad
Sattar, Yasar
Patel, Bansari
Song, David
Patel, Neel N.
Duhan, Sanchit
Cheema, Mustafa Sajjad
Naeem, Minahil
Waqar, Hafiza Hareem
Lactana, Sharaad
Alraies, M. Chadi C.
机构
关键词
Amyloidosis; Mortality; Heart Failure; Echocardiography;
D O I
10.1161/circ.148.suppl_1.16556
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A16556
引用
收藏
页数:2
相关论文
共 50 条
  • [1] A Systematic Review of Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
    Singh, Bishnu Mohan
    Bohara, Narayan
    Gautam, Kamal
    Basnet, Madan
    Sistu, K. C.
    Binod, K. C.
    Raut, Anuradha
    Phudong, Abisha
    Gautam, Jeevan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [2] Tafamidis in Transthyretin Amyloid Cardiomyopathy Effects on Transthyretin Stabilization and Clinical Outcomes
    Maurer, Mathew S.
    Grogan, Donna R.
    Judge, Daniel P.
    Mundayat, Rajiv
    Packman, Jeff
    Lombardo, Ilise
    Quyyumi, Arshed A.
    Aarts, Janske
    Falk, Rodney H.
    CIRCULATION-HEART FAILURE, 2015, 8 (03) : 519 - 526
  • [3] Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study
    Damy, Thibaud
    Garcia-Pavia, Pablo
    Hanna, Mazen
    Judge, Daniel P.
    Merlini, Giampaolo
    Gundapaneni, Balarama
    Patterson, Terrell A.
    Riley, Steven
    Schwartz, Jeffrey H.
    Sultan, Marla B.
    Witteles, Ronald
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (02) : 277 - 285
  • [4] Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
    Benjamin Li
    Jose Alvir
    Michelle Stewart
    Cardiology and Therapy, 2020, 9 : 535 - 540
  • [5] Tafamidis A Novel Treatment for Transthyretin Amyloid Cardiomyopathy
    Nawarskas, James J.
    Shephard, Emily A.
    CARDIOLOGY IN REVIEW, 2020, 28 (03) : 156 - 160
  • [6] Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial
    Li, Benjamin
    Alvir, Jose
    Stewart, Michelle
    CARDIOLOGY AND THERAPY, 2020, 9 (02) : 535 - 540
  • [7] Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
    Maurer, Mathew S.
    Schwartz, Jeffrey H.
    Gundapaneni, Balarama
    Elliott, Perry M.
    Merlini, Giampaolo
    Waddington-Cruz, Marcia
    Kristen, Arnt V.
    Grogan, Martha
    Witteles, Ronald
    Damy, Thibaud
    Drachman, Brian M.
    Shah, Sanjiv J.
    Hanna, Mazen
    Judge, Daniel P.
    Barsdorf, Alexandra I.
    Huber, Peter
    Patterson, Terrell A.
    Riley, Steven
    Schumacher, Jennifer
    Stewart, Michelle
    Sultan, Marla B.
    Rapezzi, Claudio
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11) : 1007 - 1016
  • [8] Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy
    Kazi, Dhruv S.
    Bellows, Brandon K.
    Baron, Suzanne J.
    Shen, Changyu
    Cohen, David J.
    Spertus, John A.
    Yeh, Robert W.
    Arnold, Suzanne V.
    Sperry, Brett W.
    Maurer, Mathew S.
    Shah, Sanjiv J.
    CIRCULATION, 2020, 141 (15) : 1214 - 1224
  • [9] Health impact of tafamidis in transthyretin amyloid cardiomyopathy patients: an analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the open-label long-term extension studies
    Rozenbaum, Mark H.
    Garcia, Andrea
    Grima, Daniel
    Tran, Diana
    Bhambri, Rahul
    Stewart, Michelle
    Li, Benjamin
    Heeg, Bart
    Postma, Maarten
    Masri, Ahmad
    EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, 2022, 8 (05) : 529 - 538
  • [10] Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review
    Matteo, Serenelli
    Anna, Cantone
    Federico, Sanguettoli
    Daniele, Maio
    Gioele, Fabbri
    Beatrice, Dal Passo
    Rita, Pavasini
    Elisabetta, Tonet
    Giulia, Passarini
    Claudio, Rapezzi
    Gianluca, Campo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10